← back to search

Yali Shen

Nantong University · CN
Area of research
Public Health, Environmental and Occupational Health · Surgery
Research interest
Research interests include Mace, Medicine, Acute coronary syndrome, Internal medicine, and Confidence interval.
h-index
citations
8
works
1
NIH funding
primary concept
email

Recent publications

Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial.
Journal of Clinical Oncology 2024cited by 15position: middledoi
Correlation between serum cartilage oligomeric matrix protein and major adverse cardiovascular events within 30 days in patients with acute coronary syndrome
Annals of Translational Medicine 2021cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kefeng Ding · Ministry of Education of the People's Republic of China1 papers (2024–2024)Xiangbing Deng · UCLA Health1 papers (2024–2024)Huimin Wang · Guangzhou University of Chinese Medicine1 papers (2021–2021)Biao Wang · Soochow University1 papers (2024–2024)Ping Liu · Jinan Maternity And Care Hospital1 papers (2024–2024)Dan Jiang · Hebei Medical University1 papers (2024–2024)Qing Zhang · Nantong University1 papers (2021–2021)Ling Xie · Nanjing University of Chinese Medicine1 papers (2021–2021)Yi Xiao · Nanjing University1 papers (2024–2024)Hao Sun · Jiangsu University1 papers (2024–2024)Jian Qiu · University of Fribourg1 papers (2024–2024)Bing Wu · Zhejiang Chinese Medical University1 papers (2024–2024)X. Wang · Chinese PLA General Hospital1 papers (2024–2024)Hanjiang Zeng · The First Affiliated Hospital, Sun Yat-sen University1 papers (2024–2024)Qing Guo · Hebei Medical University1 papers (2024–2024)Jing Wang · Capital Normal University1 papers (2021–2021) · 1 papers (2024–2024)Zong‐Guang Zhou · Sichuan University1 papers (2024–2024)Hao Chen · Icahn School of Medicine at Mount Sinai1 papers (2021–2021) · 1 papers (2024–2024)